206 related articles for article (PubMed ID: 4099321)
1. Progestagen-only contraception.
Lancet; 1971 Jan; 1(7688):25-6. PubMed ID: 4099321
[No Abstract] [Full Text] [Related]
2. Recent progress on systemic contraceptives.
Matsumoto S
Acta Obstet Gynaecol Jpn; 1970 Jul; 17(3):211-9. PubMed ID: 4917512
[No Abstract] [Full Text] [Related]
3. Evaluation of the contraceptive efficacy of Quingestanol acetate in daily microdose and post coitum.
Moggia A; Mischler T; Beauquis A; Zarate J; Torrado M; Ferrari F; Koremblit E
J Reprod Med; 1973 Apr; 10(4):186-92. PubMed ID: 4735194
[No Abstract] [Full Text] [Related]
4. [Colpocytological patterns caused by hormonal contraceptives].
Pescetto G; Ragni N
Minerva Ginecol; 1975 Jun; 27(6):433-9. PubMed ID: 1153120
[TBL] [Abstract][Full Text] [Related]
5. Hypertension and oral contraception.
Smith RW
Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):50-5. PubMed ID: 5164822
[No Abstract] [Full Text] [Related]
6. [Oral estro-progestational agents and the uterine cervix].
de Brux J
Pathol Eur; 1972; 7(3):283-7. PubMed ID: 4657185
[No Abstract] [Full Text] [Related]
7. Oral contraception with estrogen and progestin combinations.
Board JA
Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
[No Abstract] [Full Text] [Related]
8. Platelet aggregation during oral contraception.
Poller L; Priest CM; Thomson JM
Br Med J; 1969 Nov; 4(5678):273-4. PubMed ID: 4186656
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.
Dugdale M; Masi AT
J Chronic Dis; 1971 Mar; 23(10):775-90. PubMed ID: 4933752
[No Abstract] [Full Text] [Related]
10. [Risk of thrombophlebitis during hormonal contraception].
Ludwig H
Ther Umsch; 1971 Aug; 28(8):516-21. PubMed ID: 5119110
[No Abstract] [Full Text] [Related]
11. [Oral contraception and liver function].
Bergsjo P
Tidsskr Nor Laegeforen; 1973 Mar; 93(9):583-8. PubMed ID: 4759808
[No Abstract] [Full Text] [Related]
12. [Hormonal contraception].
Imparato E
Rass Int Clin Ter; 1970 Jan; 50(2):86-96. PubMed ID: 5436775
[No Abstract] [Full Text] [Related]
13. The sialic acid content in mouse female reproductive organs as a quantitative parameter for testing the estrogenic and antiestrogenic effect, antiestrogenic depot effect, and dissociated effect of estrogens on the uterus and vagina.
Nishino Y; Neumann F
Acta Endocrinol Suppl (Copenh); 1974; 187():3-62. PubMed ID: 4134905
[No Abstract] [Full Text] [Related]
14. Oral contraceptives: mechanism of action, dosing, safety, and efficacy.
Sondheimer SJ
Cutis; 2008 Jan; 81(1 Suppl):19-22. PubMed ID: 18338654
[TBL] [Abstract][Full Text] [Related]
15. [Mammograms in women taking oral contraceptives (author's transl)].
Brezina K; Janisch H; Müller-Tyl E
Wien Klin Wochenschr; 1973 Nov; 85(48):785-90. PubMed ID: 4796259
[TBL] [Abstract][Full Text] [Related]
16. [The effect of ovulation inhibitors on the vaginal picture and the portio epithelium].
Mehring W
Med Klin; 1965 Dec; 60(50):2016-7. PubMed ID: 5870226
[No Abstract] [Full Text] [Related]
17. [The mechanism of action of oral contraceptives].
Manuilova IA
Akush Ginekol (Mosk); 1971 Feb; 47(2):3-8. PubMed ID: 4940751
[No Abstract] [Full Text] [Related]
18. Continuous low-dose progestagen oral contraceptives.
Drug Ther Bull; 1974 Feb; 12(3):9-11. PubMed ID: 4457303
[No Abstract] [Full Text] [Related]
19. The haemostatic mechanism in oral contraception.
Hilden M; Amris CJ; Starup J
Acta Obstet Gynecol Scand; 1967; 46(4):562-71. PubMed ID: 6082549
[No Abstract] [Full Text] [Related]
20. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
Basdevant A; Guy-Grand B
Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
